This study demonstrates that activation of α7nAChR with Ani could ameliorate hyperkalemia during CS through E2-induced enhancement of insulin sensitivity, and thus to decrease on-site mortality (Figure 9). The gene discussed is CHRNA7; the disease is Hyperkalemia.